Diagnostic value of FDG-PET/CT in the diagnostic work-up of inflammation of unknown origin

Nuklearmedizin. 2023 Feb;62(1):27-33. doi: 10.1055/a-1976-1765. Epub 2023 Jan 9.

Abstract

Introduction The present study aims to evaluate the clinical diagnostic value of FDG-PET/CT in patients with inflammation of unknown origin. Material and methods We retrospectively analyzed data of 130 patients who presented general inflammatory symptoms and/or elevated level of CRP and underwent FDG-PET/CT for the purpose of identifying unknown foci of inflammation. The accuracy of PET/CT findings was assessed against the standard of eventual clinical diagnosis e.g. results of pathology, microbiology or other imaging methods. Results In 99/130 patients (76 %) a final diagnosis was established, FDG-PET/CT showed a sensitivity and specificity of each 93 %. A decreased pseudocholinesterase is associated with a higher SUVmax value and with a higher CRP value whereas no significant relationship was found between elevated CRP values and the SUVmax, although higher CRP values are associated significantly with a true positive PET/CT result. Conclusion FDG-PET/CT is a highly sensitive, specific and accurate method for the detection of foci of inflammation of unknown origin. The combination of decreased pseudocholinesterase and increased CRP levels may be a useful tool to select patients for FDG PET/CT.

MeSH terms

  • Butyrylcholinesterase
  • Fluorodeoxyglucose F18*
  • Humans
  • Inflammation / diagnostic imaging
  • Positron Emission Tomography Computed Tomography* / methods
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Retrospective Studies

Substances

  • Fluorodeoxyglucose F18
  • Butyrylcholinesterase
  • Radiopharmaceuticals